Influence of intense multidisciplinary follow-up and orlistat on weight reduction in a primary care setting
- PMID: 15679893
- PMCID: PMC548505
- DOI: 10.1186/1471-2296-6-5
Influence of intense multidisciplinary follow-up and orlistat on weight reduction in a primary care setting
Abstract
Background: Obesity is the most common health problem in developed countries. Recently, several physicians' organizations have issued recommendations for treating obesity to family physicians, including instructions in nutrition, physical activity and medications. The aim of this study was to examine if effective weight-reducing treatment can be given by a family physician. It compares regular treatment with intensive treatment that include close follow-up and orlistat treatment.
Methods: The study was conducted in three primary care clinics. 225 patients were divided into three groups according to their choice. Group A received a personal diet with fortnightly meetings with the family physician and dietitian and orlistat treatment. Group B received a general diet, monthly meetings with the family physician only and orlistat treatment. Group C received a personal diet, monthly meetings with the dietitian only and no drug treatment. The primary endpoint was reduction of at least 5% of the initial weight during the study period.
Results: A greater percentage of patients in group A achieved their weight reduction goals than in other groups (51%, 13% and 9% in groups A, B and C, respectively, p < 0.001). There was a significant reduction in triglycerides in all groups, a significant reduction of low density lipids (LDL) in groups A and B and no significant difference in high density lipids (HDL) in any group.
Conclusions: Significant weight reduction was obtained in a family physician setting. Further research is needed to evaluate if, by providing the family physician with the proper tools, similar success can be achieved in more clinics.
Similar articles
-
X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.Diabetes Obes Metab. 2005 Nov;7(6):699-708. doi: 10.1111/j.1463-1326.2005.00483.x. Diabetes Obes Metab. 2005. PMID: 16219013 Clinical Trial.
-
Cholesterol lowering effect of dietary weight loss and orlistat treatment--efficacy and limitations.Aliment Pharmacol Ther. 2004 Jun 1;19(11):1173-9. doi: 10.1111/j.1365-2036.2004.01966.x. Aliment Pharmacol Ther. 2004. PMID: 15153170 Clinical Trial.
-
Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia.Med Pregl. 1999 Sep-Oct;52(9-10):323-33. Med Pregl. 1999. PMID: 10624380 Clinical Trial. Croatian, English.
-
Orlistat (Xenical) in the management of obesity.Ann Acad Med Singap. 2000 Jul;29(4):419-20. Ann Acad Med Singap. 2000. PMID: 11056767 Review. No abstract available.
-
[The role of orlistat in the treatment of obesity].Orv Hetil. 2005 Mar 13;146(11):493-8. Orv Hetil. 2005. PMID: 15813187 Review. Hungarian.
Cited by
-
Role of the family doctor in the management of adults with obesity: a scoping review.BMJ Open. 2018 Feb 16;8(2):e019367. doi: 10.1136/bmjopen-2017-019367. BMJ Open. 2018. PMID: 29453301 Free PMC article.
-
Orlistat: a review of its use in the management of obesity.Drugs. 2006;66(12):1625-56. doi: 10.2165/00003495-200666120-00012. Drugs. 2006. PMID: 16956313 Review.
-
Over-the-counter orlistat: early experiences, views and attitudes of community pharmacists in Great Britain.Int J Clin Pharm. 2011 Aug;33(4):627-33. doi: 10.1007/s11096-011-9516-z. Epub 2011 May 15. Int J Clin Pharm. 2011. PMID: 21573977 Clinical Trial.
-
Views and Experiences of Adults who are Overweight and Obese on the Barriers and Facilitators to Weight Loss in Southeast Brazil: A Qualitative Study.Int J Qual Stud Health Well-being. 2020 Dec;15(1):1852705. doi: 10.1080/17482631.2020.1852705. Int J Qual Stud Health Well-being. 2020. PMID: 33250018 Free PMC article.
References
-
- Bray GA. Contemporary Diagnosis and Management of Obesity. City: Handbooks in Health Care Company; 1998.
-
- Hill JO, Wyatt H. Outpatient management of obesity: a primary care perspective. Obes Res. 2002;2:124–130. - PubMed
-
- US Department of Health and Human Services . The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity. Rockville, Md; 2001.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical